Mihai Gheorghiade - Concepedia

Author

Mihai Gheorghiade

Also Known As

Baschiera, Fabio, Gheorghiade, Mihai, M GHEORGHIADE, M Gheorghiade, M. Gheorghiade, MIHAI GHEORGHIADE, Mihai Gheorghiade

304

Publications

23.3K

Citations

H-Index

Concepts

All Affiliations

Northwestern University University of California, Los Angeles Duke Medical Center Cleveland Clinic Baylor University Medical Center

About

Mihai Gheorghiade is an author at Northwestern University specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	85	11.7K
2	Public Health	18	19	3.2K
3	Health Sciences	6	6	303
4	Nursing	4	4	260
5	Applied Physiology	1	1	50

Mihai Gheorghiade

120

Publications

19.5K

Citations

H-Index

Page 1

	Year	Citations
The Global Health and Economic Burden of Hospitalizations for Heart Failure Andrew P. Ambrosy, Gregg C. Fonarow, Javed Butler, Journal of the American College of Cardiology HospitalizationHeart FailureHealth PolicyHealth EconomicsGlobal Health	2014	2K
Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia Robert W. Schrier, Mihai Gheorghiade, Tomás Berl, New England Journal of Medicine	2006	1.2K
Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure Gregg C. Fonarow, Wendy Gattis Stough, William T. Abraham, Journal of the American College of Cardiology Heart FailureCardiovascular DiseaseOutcomes ResearchCardiac CareMedicine	2007	1.1K
Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure Mihai Gheorghiade, William T. Abraham, Nancy M. Albert, JAMA	2006	963
Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors Milton Packer, Mihai Gheorghiade, James B. Young, New England Journal of Medicine	1993	823
Rehospitalization for Heart Failure Mihai Gheorghiade, Muthiah Vaduganathan, Gregg C. Fonarow, Journal of the American College of Cardiology Heart FailureCardiovascular DiseaseCardiac CareMedicineCardiology	2012	714
Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE> Mihai Gheorghiade JAMA	2004	646
Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure William T. Abraham, Gregg C. Fonarow, Nancy M. Albert, Journal of the American College of Cardiology Prognostic EvaluationHeart FailureCardiovascular DiseaseMedicineCardiac Care	2008	588
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial Andrew P. Ambrosy, Peter S. Pang, Sadiya S. Khan, European Heart Journal	2013	553
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST) Christopher M. O’Connor, Wendy A. Gattis, Barry F. Uretsky, American Heart Journal Heart FailureCardiovascular DiseasePatient SafetyContinuous Intravenous DobutaminePharmacotherapy	1999	515

Page 1